Danaher Corporation

Stock Chart, Company Information, and Scan Results

$205(as of Aug 27, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Danaher Corporation Company Information, Fundamentals, and Technical Indicators

Stock Price$205
Ticker SymbolDHR
ExchangeNyse
SectorHealthcare
IndustryDiagnostics & Research
Employees61,000
CountyUSA
Market Cap$147,685.7M
EBIDTA7,521.0M
10-Day Moving Average208.84
P/E Ratio43.19
20-Day Moving Average204.40
Forward P/E Ratio27.25
50-Day Moving Average201.00
Earnings per Share4.70
200-Day Moving Average209.94
Profit Margin9.35%
RSI50.80
Shares Outstanding716.1M
ATR4.76
52-Week High278.43
Volume2,502,990
52-Week Low170.73
Most Recent Support Level203.89
Book Value52,342.0M
Most Recent Resistance Level212.57
P/B Ratio2.82
Upper Keltner215.11
P/S Ratio6.14
Lower Keltner193.70
Debt-to-Equity Ratio215.11
Next Earnings Date10/21/2025
Cash Surplus-3,835.0M
Next Ex-Dividend DateUnknown

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a partnership with AstraZeneca PLC to develop and commercialize diagnostic tools and tests. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and

Danaher Corporation In Our Stock Scanner

As of Aug 28, 2025
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.